Combining Deep Learning Algorithm to AREDS Severity Scoring Improves AMD Tracking

New Study Combining Deep Learning Algorithm to AREDS Severity Scoring Improves AMD Tracking by: Kevin Kunzmann The binary judgment capabilities of deep learning (DL) algorithms may actually complement the common severity stratification scale used for age-related...

What Eye Colors Says About Your Health

What Eye Colors Says About Your Health by: Dr. O Eyes are one of the most beautiful and powerful components of the human body. According to common knowledge, they are our window to the outside world and they have the ability to express our inner emotions. With our...

Kodiak Sciences Announces Completion of Enrollment

Kodiak Sciences Announces Completion of Enrollment in the Company's Phase 1 Safety and Tolerability Study in Patients with Retinal Disease PALO ALTO, Calif., Aug. 31, 2018 /PRNewswire/ -- Kodiak Sciences Inc., a clinical stage biopharmaceutical company specializing in...

3D printed bionic eye prototype could one day restore sight

3D printed bionic eye prototype could one day restore sight Researchers hope the invention could one day restore sight for the blind. by: Charlie Osborne for Between the Lines Researchers have used 3D printing technologies to create light receptors on a hemispherical...

Targeting one enzyme could treat cancer, diabetes, and obesity

Targeting one enzyme could treat cancer, diabetes, and obesity by: Catharine Paddock PhD Fact checked by Jasmin Collier The uncovering of the molecular acrobatics of a key cell enzyme could lead to new treatments for cancer and metabolic diseases such as obesity and...

Treat-and-extend increasingly gains favor for individualized, proactive management of neovascular AMD

Treat-and-extend increasingly gains favor for individualized, proactive management of neovascular AMD by: Ocular Surgery News U.S. Edition An appropriate treatment modality is key to the success of anti-VEGF therapy in neovascular age-related macular degeneration....

Possible New Vision Loss Treatment in the Works

Possible New Vision Loss Treatment in the Works by: Devon Andre Age-related macular degeneration (AMD)  is the most common cause of vision loss. It’s hard to completely prevent because it’s main risk factor is aging. Until we find a way to stop aging, AMD will...

Hopkins researchers chart a course

Hopkins researchers chart a course for AI-aided diagnosis of degenerative eye conditions Team from APL and Wilmer Eye Institute discover that machine diagnostics using deep learning can match the performance of human ophthalmologists Artificial intelligence could...

Device Extends Treatment

This is additional information to a recent article called "Genentech’s first implantable drug delivery system shows promising results in phase 2 wet AMD trial" Device Extends Treatment Interval for AMD Refill with anti-VEGF therapy pushed to 15 months by Charles...

Research aims to personalize

Research aims to personalize AMD therapies By: Joan W. Miller VANCOUVER, British Columbia — Much like the development of anti-VEGF was transformational in the treatment of age-related macular degeneration, the future identification of key pathways, potential...
On